Lori Maxwell
Impact in
- Cancer Research top 10%
- Cancer, Hypoxia, and Metabolism
- Biochemistry top 10%
- Eicosanoids and Hypertension Pharmacology
Papers in
- Oncology 4
- CAR-T cell therapy research 2
-
- Immunotherapy and Immune Responses 2
- Co-authors
- Charles H. Graham (3 shared papers)D. Robert Siemens (2 shared papers)Lisa J. Frederiksen (2 shared papers)Michael Adams (2 shared papers)Michael A. Adams (1 shared paper)Jeremy P.W. Heaton (1 shared paper)Richard Sullivan (1 shared paper)Shannyn K. Macdonald-Goodfellow (1 shared paper)
- Journals
- Neuro-Oncology (2 papers)Clinical Cancer Research (1 paper)CHEST Journal (1 paper)Scandinavian Journal of Immunology (1 paper)JNCI Journal of the National Cancer Institute (1 paper)
- Partner nations
- CanadaUnited StatesNetherlands
In The Last Decade
Lori Maxwell
12 papers receiving 507 citations
Peers
Comparison fields: 5 of 75
- Cancer Research 150
- Biochemistry 59
- Toxicology 15
- Oncology 111
- Physiology 100
Countries citing papers authored by Lori Maxwell
This map shows the geographic impact of Lori Maxwell's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lori Maxwell with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lori Maxwell more than expected).
Fields of papers citing papers by Lori Maxwell
This network shows the impact of papers produced by Lori Maxwell. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lori Maxwell. The network helps show where Lori Maxwell may publish in the future.
Co-authors
The 25 scholars most cited alongside Lori Maxwell, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2001 | 142 | |
| 2 | 2007 | 119 | |
| 3 | 2003 | 93 | |
| 4 | 2013 | 43 | |
| 5 | 1999 | 40 | |
| 6 | Expression of epithelial-like markers and class I major histocompatibility antigens by a murine carcinoma growing in the mammary gland and in metastases: orthotopic site effects. | 1988 | 30 |
| 7 | 2007 | 22 | |
| 8 | 2013 | 15 | |
| 9 | 2020 | 9 | |
| 10 | 1991 | 4 | |
| 11 | 2008 | 3 | |
| 12 | The Goldilocks Dilemma: A Case Study toward a "Just Right" Model of Service-Learning | 2016 | 1 |
| 13 | 2015 | 1 |
About Lori Maxwell
Lori Maxwell is a scholar working on Oncology, Immunology, Genetics, Molecular Biology and Genetics, having authored 13 papers that have together received 522 indexed citations. Recurring topics across this work include Immunotherapy and Immune Responses (2 papers), CAR-T cell therapy research (2 papers), Virus-based gene therapy research (2 papers), DNA Repair Mechanisms (1 paper), Nursing Education, Practice, and Leadership (1 paper), Epigenetics and DNA Methylation (1 paper), Pleural and Pulmonary Diseases (1 paper) and Microfluidic and Bio-sensing Technologies (1 paper). The work is most often cited by research in Cancer Research (150 citations), Biochemistry (59 citations), Toxicology (15 citations), Oncology (111 citations) and Physiology (100 citations). Lori Maxwell has collaborated with scholars based in Canada, United States and Netherlands. Frequent co-authors include Charles H. Graham, D. Robert Siemens, Lisa J. Frederiksen, Michael Adams, Michael A. Adams, Jeremy P.W. Heaton, Richard Sullivan, Shannyn K. Macdonald-Goodfellow, Brian M. Bennett and B E Elliott. Their work appears in journals such as Neuro-Oncology, Clinical Cancer Research, CHEST Journal, Scandinavian Journal of Immunology and JNCI Journal of the National Cancer Institute.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.